Clinical Trial

Genetic Susceptibility to Listeriosis

Study acronym: Listeria-GEN
Recruiting
View on ClinicalTrials.gov →
Summary
Listeriosis is a rare, severe foodborne infection, responsible for severe invasive infections. It occurs in the great majority of cases in elderly patients and / or patients with comorbidities, with a deficit of innate or cellular immunity. Pregnancy is also a risk factor. The Multicentric Observational NAtional Analysis of Listeriosis and Listeria (MONALISA) is an ongoing national case-control prospective study on listeriosis implemented since 2009 to study risk and prognosis factors for listeriosis. In this cohort, which enrolled 902 patients on 1 August 2014, 7% of patients with neurolisteriosis are under 40 years of age and have no identified risk factor. Genetic susceptibility is suspected in these patients. Genetic susceptibility could also explain the inconstant development of a neurolisteriosis or fetal infection, as well as the particular severity of some infections (death, foetal loss, neurological sequelae). The aim of the study is to identify genetic susceptibility to Listeriosis.
Protocol Amendment History 7 amendments
This ClinicalTrials.gov record has been amended 7 times since 2017-11-24; most recent amendment 2025-09-18.
Status change: Not Yet Recruiting → Recruiting 2017-12-06
Trial Details
NCT Number NCT03357536
Lead Sponsor Institut Pasteur
Collaborators: Icahn School of Medicine at Mount Sinai
Conditions Listeriosis
Enrollment 100 participants
Start Date 2017-11-28
Primary Completion 2027-11-30 (estimated)
Study Completion 2027-11-30 (estimated)
Updated on ClinicalTrials.gov 2025-09-19